Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis

References

• Tleyjeh IM, Bin Abdulhak AA, Riaz M, et al. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One. 2012;7:e50836.
   PubMed Web of Science ®Google Scholar
• Janarthanan S, Ditah I, Adler DG, et al. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001–1010.
   PubMed Web of Science ®Google Scholar
• Kwok CS, Arthur AK, Anibueze CI, et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107:1011–1019.
   PubMed Web of Science ®Google Scholar
• Abou Chakra CN, Pepin J, Sirard S, et al. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One. 2014;9:e98400.
   PubMed Web of Science ®Google Scholar
• Deshpande A, Pasupuleti V, Thota P, et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015;36:452–460.
   PubMed Web of Science ®Google Scholar
• Knight DR, Giglio S, Huntington PG, et al. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14. J Antimicrob Chemother. 2015;70:2992–2999.
   PubMed Web of Science ®Google Scholar
• Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control. 2013;2:21.
   PubMed Web of Science ®Google Scholar
• Freeman J, Vernon J, Morris K, et al., Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes’ Study G. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin Microbiology Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2015;21(248):e9e16.
   Google Scholar
• Stewart DB, Hegarty JP. Correlation between virulence gene expression and proton pump inhibitors and ambient pH in Clostridium difficile: results of an in vitro study. J Med Microbiol. 2013;62:1517–1523.
   PubMed Web of Science ®Google Scholar
• Hallas J. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Epidemiology. 1996;7:478–484.
   PubMed Web of Science ®Google Scholar
• AsPEN collaborators, Andersen M, Bergman U, Choi NK, et al. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiol Drug Saf. 2013;22:700–704. Epub 2013/May/09.
   PubMed Web of Science ®Google Scholar
• Lai EC, Man KK, Chaiyakunapruk N, et al. Brief report: databases in the Asia-Pacific Region: the potential for a distributed network approach. Epidemiology. 2015;26:815–820.
   PubMed Web of Science ®Google Scholar
• World Health Organization. ATC/DDD Index. [cited 2016 Sep 13] Available from: http://www.whocc.no/atc_ddd_index/
   Google Scholar
• Wahab IA, Pratt NL, Wiese MD, et al. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22:496–502.
   PubMed Web of Science ®Google Scholar
• Pratt NL, Ilomaki J, Raymond C, et al. The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study. BMC Med Res Methodol. 2014;14:66.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Vancomycin Hydrochloride Product Information Auckland, New Zealand: Drugs.com; 2015 [cited 2016 Feb 19]. Available from: http://www.drugs.com/pro/vancomycin-hydrochloride.html.
   Google Scholar
• Dial S, Delaney JA, Schneider V, et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ: Can Med Assoc Journal. 2006;175:745–748.
   PubMed Web of Science ®Google Scholar
• Pratt N, Andersen M, Bergman U, et al. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiol Drug Saf. 2013;915–924. DOI:10.1002/pds.3440.
   PubMed Web of Science ®Google Scholar
• Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18:483–491.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green SE. Cochrane Handbook for Systematic Reviews of Interventions The Cochrane Collaboration, 2011 [ Available from: http://training.cochrane.org/handbook
   Google Scholar
• Rothman K. Modern Epidemiology. Boston, USA: Little Brown and Company; 1986.
   Google Scholar
• Takahashi M, Mori N, Bito S. Multi-institution case-control and cohort study of risk factors for the development and mortality of Clostridium difficile infections in Japan. BMJ Open. 2014;4:e005665.
   Google Scholar
• Mori N, Aoki Y. Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: a retrospective, case-control study in a tertiary care hospital in Japan. J Infect Chemother. 2015;21:864–867.
   PubMedGoogle Scholar
• Hikone M, Ainoda Y, Tago S, et al. Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital. Clin Exp Gastroenterol. 2015;8:191–196.
   PubMed Web of Science ®Google Scholar
• Mizui T, Teramachi H, Tachi T, et al. Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy. Die Pharm. 2013;68:706–710.
   PubMed Web of Science ®Google Scholar
• Kim JW, Lee KL, Jeong JB, et al. Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea. World J Gastroenterol. 2010;16:3573–3577.
   PubMed Web of Science ®Google Scholar
• Kim YG, Graham DY, Jang BI. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol. 2012;46:397–400.
   PubMed Web of Science ®Google Scholar
• Lin YC, Huang YT, Lee TF, et al. Characteristics of patients with Clostridium difficile infection in Taiwan. Epidemiol Infect. 2013;141:2031–2038.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Hung YP, Liu HC, et al. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization. J Microbiol Immunol Infect. 2015;48:183–189.
   PubMedGoogle Scholar
• Nerandzic MM, Pultz MJ, Donskey CJ. Examination of potential mechanisms to explain the association between proton pump inhibitors and Clostridium difficile infection. Antimicrob Agents Chemother. 2009;53:4133–4137.
   PubMed Web of Science ®Google Scholar
• Hegarty JP, Sangster W, Harris LR, et al. Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection. Surgery. 2014;156:972–978.
   PubMed Web of Science ®Google Scholar
• Furuta T, Shirai N, Sugimoto M, et al. Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metab Pharmacokinet. 2005;20:153–167.
   PubMedGoogle Scholar
• Australian Government Department of Health. The Pharmaceutical Benefits Scheme. Canberra: Australian Government Department of Health; 2015 [ Available from: http://www.pbs.gov.au/pbs/home;jsessionid=224yhbqlvj1l1dw6d4npdv7mj
   Google Scholar
• Korea Ministry of Health and Welfare. Health benefit management. Wonju: Korea Health Insurance Review and Assessment Service; 2015. Seoul: Korea Ministry of Health and Welfare 2015 [cited 2016 Feb 19]. Available from: http://www.hira.or.kr/eng/index.html#&panel1-2
   Google Scholar
• US Department of Health and Human Services Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta, GA, USA: Centers for Disease Control and Prevention; 2013.
   Google Scholar